Abstract: Disclosed is a stable water-in-oil emulsion system formed of an organopolysiloxane elastomer, a vehicle in which the elastomer is dispersed or dispersible, a stabilizing agent, a surfactant and an aqueous component and a process for forming the stable water-in-oil emulsion. The stabilized water-in-oil emulsion is useful in personal care products.

Abstract: A lock valve disposed between a pulling pot and a lock chamber is opened at the start of the pulling process and thereby uncovers a lock entrance for the crystal that is to be pulled, and together with a gasket closes the lock entrance after the end of the pulling process and thereby hermetically separates the pulling pot from the lock chamber. The gasket (9) is protected during the pulling of the crystal by a guard (15, 16) against the thermal radiation of the hot crystal.

Abstract: Lenses are brought individually or in pairs on a transport device (12) to a continuous vacuum apparatus (1) equipped with a rotating substrate carrier (3). The eyeglass lenses (13) are introduced through a system of locks (15) into the continuous vacuum apparatus (1), where they are coated in at least one controllable coating station (5, 6, 7) with at least one transparent layer and then sent back to the transport device (12). The eyeglass lenses (13) are given codes (18), and the codes are read by a code reader (19). The coating parameters of the individual coating stations (5, 6, 7) and the drive of the substrate carrier (3) are controlled by the code reader (19).

Abstract: The invention relates to a process of providing a scratch-resistant coating for a lens made of an optical material comprising synthetics. In order for the synthetic material, for example a CR 39, to be protected against scratches, a very thin adhesion layer of SiO is applied first, and is subsequently provided with a thick SiO.sub.2 layer. Both layers are deposited in a vacuum chamber which comprises both a thermal vaporizer for vaporizing the coating materials and a plasma source for irradiating the substrate simultaneously with application of the vaporized coating material.

Abstract: Materials containing vaporizable substances are exposed successively in at least two treatment chambers (10, 13, 14), which can be closed off with respect to each other, to a series of decreasing pressures and increasing temperatures. The vaporizable substances are exhausted separately from each treatment chamber (10, 13, 14) and at least partially condensed and collected. The solid materials are discharged from the last treatment chamber (14). The treatment chambers (10, 13, 14) can be closed off against each other, against the atmosphere, and against any other units which may be connected to them downline (17, 18) by vacuum valves (11, 12, 115, 16) and are connected to vacuum lines (10a, 13a, 14a) in which condensers (10b, 13b, 14b) and vacuum pumps (10c, 13c, 14c) are installed.

Abstract: The invention concerns new aminoalkylmaleimides of the general formula I ##STR1## in which R.sub.1 and R.sub.2 are the same or different and represent hydrogen or a C.sub.1 -C.sub.4 alkyl group and A represents a straight-chain or branched, saturated or unsaturated alkylene group with 2 to 6 carbon atoms which is interrupted, if desired, by an oxygen or sulphur atom or a carbonyl group, as well as their corresponding acid addition salts.The present invention also concerns amidoalkylmaleimide derivatives formed from compounds of the general formula I and immunological binding partners. In addition, the invention concerns immunological conjugates which can be produced by reaction of the amidoalkylmaleimide derivatives with peptides or proteins.The subject matter of the present invention are also the corresponding processes of production of the compounds according to the present invention as well as the use of these conjugates in diagnostic methods of determination, in particular in immunoassays.

Abstract: In a monopolar electrolysis cell for chlor-alkali electrolysis by the diaphragm or membrane process, the cathodic and anodic electrode structures extend in the vertical direction, the anodic structure being surrounded by the cathodic electrode structure. In the area of the active electrode surfaces, an upward-directed flow of electrolyte-gas mixture is produced as a result of the gas bubbles generated electrolytically in the electrode gap, whereupon the electrolyte is then degassed. The degassed electrolyte, because of its higher specific gravity, then flows down through a flow channel inside the anodic electrode structure, this channel being formed by vertically oriented feed conductors and U-shaped flow guide plates.

Abstract: The invention provides a new Schwann cell-mitogenic factor of molecular weight about 43 to 45 kilodaltons, when isolated by SDS-PAGE. The invention provides therapeutic formulation comprising the new factor, and the use of the factor and the said formulations in treating conditions which involve a factor-sensitive or factor-responsive cell type.

Abstract: A process for the activation of disulphide linked recombinant proteins expressed in prokaryotes is described. The process includes cell digestion, solubilization under denaturing and reducing conditions and activation under oxidizing conditions in the presence of GSH/GSSG and a non-denaturing amount of a denaturing agent.

Abstract: An information lamp flashes when instability is detected, whether the system is switched on, off or limited in its functional scope. When the traction control system is switched off or limited in its functional scope and no instability is detected, the lamp lights up continuously.

Abstract: Disclosed are organosilane polycondensation products prepared by hydrolysis of an hydrogen salt of an aminosilane compound or by hydrolysis of an aminosilane followed by reaction with an alkyl salt. The compounds are useful in forming stable aqueous solutions and as adhesion promoters between inorganic and organic surfaces.

Abstract: This invention relates to human IL-3 variants. The human IL-3 variants are used in pharmaceutical compositions, in methods for modulating proliferation, differentiation or functional activation of cells expressing the IL-3 receptor, and in methods of treatment.

Abstract: A process for the production of 2-cyanoiminothiazolidine by reaction of 2-aminoethanethiol (cysteamine) with a dialkyl-N-cyanoimidocarbonate.

Abstract: Tumor rejection antigens derived from tumor rejection precursor MAGE-3 have been identified. These "TRAS" bind to the MHC-class I molecule HLA-A2, and the resulting complexes stimulate the production of cytolytic T cell clones which lyse the presenting cells. The peptides and complexes may be used diagnostically, therapeutically, and as immunogens for the production of antibodies, or as targets for the generation of cytolytic T cell clones.

Abstract: A film transporting apparatus for a film processing system. The apparatus includes a pair of frame members pivotably connected to each other to be opened and closed, a transport mechanism provided to each of the frame members and operable to transport a film along a predetermined film transport passage when the frame members are closed, an optical sensor for detecting film information including a light emitting portion provided in one of the frame members and a light receiving portion provided in the other frame member, positioning engaging portions provided respectively to the frame members and coming into engagement with each other in association with a pivotal movement of the frame members to a closed state. The apparatus further includes a movable frame member movably provided to one of the frame members.

Abstract: In a multi-layer coating for a material of good transparency for visible light, with an emissivity e<0.04 and a light transmission T.gtoreq.78% and with two silver layers of different thickness, three oxide coatings are provided, and very thin metal or metal suboxide coatings as blockers, the oxide layers being alloys of the metals SnMg, SnAl, SnZr, SnTi or SnTa.

Abstract: In a circuit arrangement for a brake system with anti-lock system and/or traction control with input circuits, output circuits, control circuits, monitoring circuits, comparator circuits and circuits for switching off the control in the event of a fault, a continuous monitoring of the control circuits and of the monitoring circuits is made possible. Both the control circuits and the monitoring circuits comprise watchdog circuits for processing a watchdog algorithm which tests the functioning of the control circuits and monitoring circuits and comparator circuits for comparing the results of the watchdog algorithms respectively processed in the watchdog circuits. The output circuits only enable the control if both the control signals output by the control circuits correspond to the corresponding signals of the monitoring circuits and the results of the watchdog algorithms respectively processed in the watchdog circuits correspond.

Abstract: A method and a device for electronically controlling or adjusting a brake system of a vehicle is proposed, in which brake system the characteristic braking curve of the trailer is adapted to a prescribed characteristic braking curve of the towing vehicle, in order to minimize the longitudinal forces between a towing vehicle and a trailer during a braking process, in such a way that the braking of the entire road train takes place in accordance with the prescribed characteristic braking curve of the towing vehicle.

Abstract: A vacuum kneading and extruding method includes the steps of separately and continuously measuring plural types of material and continuously feeding the material into a kneading and degassing tank; kneading the plural types of material fed, and degassing the material by decompressing a material accommodating space into a vacuum; kneading and transporting the material in a decompressed condition through a multi-stage kneading mechanism; and forming and extruding kneaded material in a predetermined shape. An apparatus for use in executing this method is included.

Abstract: A method which assists in the early diagnosis of rejection in a liver transplant recipient comprises measuring an increase in plasma or serum alpha glutathione S-.[.tranferase.]..Iadd.transferase.Iaddend.(.alpha.-GST) from said recipient in the absence of or preceding any change in plasma or serum transaminase. .alpha.-GST is most suitably measured by enzymeimmunoassay, using a solid phase antibody which is monospecific for .alpha.-GST. The monospecific antibody cross-reacts with the .alpha.-GST dimers B.sub.1 B.sub.1, B.sub.1 B.sub.2 and B.sub.2 B.sub.2.